Actuate Therapeutics Ownership | Who Owns Actuate Therapeutics?

Actuate Therapeutics Ownership Summary

Actuate Therapeutics is owned by 59.62% institutional investors, 15.36% insiders, and 25.03% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 43.23% of ACTU shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.20% of its assets in Actuate Therapeutics shares.

ACTU Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Actuate Therapeutics	59.62%	15.36%	25.03%
Sector	Healthcare Stocks	50.53%	12.40%	37.07%
Industry	Biotech Stocks	48.96%	12.12%	38.92%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bios capital management, lp	10.05M	43.23%	$27.54M
Voss capital	1.73M	7.42%	$4.73M
Vanguard group	529.11K	2.47%	$3.24M
Blackrock funding, inc. /de	427.15K	1.84%	$1.17M
Geode capital management	228.33K	0.98%	$625.63K
Palogic value management	100.00K	0.43%	$274.00K
Northern trust	97.85K	0.42%	$268.11K
Texas capital bank wealth management services	94.59K	0.41%	$259.18K
State street	66.03K	0.28%	$180.92K
Vanguard fiduciary trust	62.59K	0.27%	$171.50K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bios capital management, lp	10.05M	52.09%	$27.54M
Voss capital	1.73M	0.25%	$4.73M
Palogic value management	100.00K	0.12%	$274.00K
Abs direct equity fund	50.00K	0.10%	$137.00K
Texas capital bank wealth management services	94.59K	0.02%	$259.18K
Rock creek group, lp	39.26K	0.01%	$107.58K
Sfmg	33.00K	0.01%	$90.42K
Gleason group	19.03K	0.01%	$52.14K
Eversource wealth advisors	2.48K	0.00%	$58.30K
Bridgeway capital management	30.98K	0.00%	$84.89K

Top Buyers

Holder	Shares	% Assets	Change
Voss capital	1.73M	0.25%	425.00K
Vanguard group	529.11K	-	213.10K
Palogic value management	100.00K	0.12%	100.00K
Vanguard fiduciary trust	62.59K	-	62.59K
Abs direct equity fund	50.00K	0.10%	43.40K

Top Sellers

Holder	Shares	% Assets	Change
Connective capital management	-	-	-113.27K
Sigma planning	-	-	-23.68K
Jane street group	-	-	-16.63K
Mercer global advisors inc /adv	-	-	-16.34K
Marshall wace, llp	-	-	-16.11K

New Positions

Holder	Shares	% Assets	Change	Value
Palogic value management	100.00K	0.12%	100.00K	$274.00K
Vanguard fiduciary trust	62.59K	-	62.59K	$171.50K
Aqr capital management	27.11K	-	27.11K	$74.28K
Goldman sachs group	12.41K	-	12.41K	$34.00K
Vanguard global advisers	5.10K	-	5.10K	$13.98K

Sold Out

Holder	Change
Root financial partners	-5.00
Mai capital management	-6.00
Wealth preservation advisors	-7.00
Sterling capital management	-40.00
Amalgamated bank	-298.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	60	36.36%	13,857,722	5.70%	59	1.59%	41	36.67%	10	42.86%
Dec 31, 2025	33	-21.43%	12,914,920	7.39%	60	1.61%	23	4.55%	5	-58.33%
Sep 30, 2025	42	10.53%	11,416,022	1.77%	58	1.76%	21	-36.36%	12	500.00%
Jun 30, 2025	37	48.00%	11,216,230	7.83%	57	2.02%	32	68.42%	2	100.00%
Mar 31, 2025	25	31.58%	10,401,592	2.82%	53	0.37%	19	35.71%	1	-50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	287.38K	1.20%	-
Vanguard Morn Total Stk Mkt Idx Investor	287.38K	1.20%	-
Vanguard MStar Total Stk Mkt Idx Invest	287.38K	1.20%	-
Vanguard Institutional Extnd Mkt Idx Tr	106.05K	0.44%	-
Fidelity Small Cap Index	94.60K	0.40%	2.04K
iShares Russell 2000 Growth ETF	73.72K	0.31%	-480.00
Vanguard Russell 2000 ETF	47.85K	0.20%	984.00
Fidelity Extended Market Index	47.94K	0.20%	-3.98K
iShares Micro-Cap ETF	37.73K	0.16%	-504.00
Xtrackers Russell 2000 ETF 1C	36.03K	0.15%	-369.00

Recent Insider Transactions

Date	Name	Activity	Value
Jan 05, 2026	THOMSON TODD S	Sell	$1.62M
Jun 27, 2025	Bios Equity COF, LP	Buy	$500.00K
Jun 27, 2025	Bios Equity COF, LP	Buy	$500.00K
Jun 27, 2025	Kreis Leslie W.	Buy	$500.00K
Jun 27, 2025	Kreis Leslie W.	Buy	$500.00K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	-
2026 Q2	-	-
2026 Q1	-	1
2025 Q2	6	-
2014 Q2	-	-

ACTU Ownership FAQ

Who Owns Actuate Therapeutics?

Actuate Therapeutics shareholders are primarily institutional investors at 59.62%, followed by 15.36% insiders and 25.02% retail investors. The average institutional ownership in Actuate Therapeutics's industry, Biotech Stocks , is 48.96%, which Actuate Therapeutics exceeds.

Who owns the most shares of Actuate Therapeutics?

Actuate Therapeutics’s largest shareholders are Bios capital management, lp (10.05M shares, 43.23%), Voss capital (1.72M shares, 7.42%), and Vanguard group (529.11K shares, 2.47%). Together, they hold 53.13% of Actuate Therapeutics’s total shares outstanding.

Does Blackrock own Actuate Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Actuate Therapeutics.

Who is Actuate Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Actuate Therapeutics’s biggest shareholder by percentage of total assets invested, with 52.09% of its assets in 10.05M Actuate Therapeutics shares, valued at 27.54M$.

Who is the top mutual fund holder of Actuate Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Actuate Therapeutics shares, with 1.20% of its total shares outstanding invested in 287.38K Actuate Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools